EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insights into Acinetobacter baumannii AMA205’s Unprecedented Antibiotic Resistance

German Matias Traglia iD, Fernando Pasteran iD, Samyar Moheb, Usman Akhtar, Sebastian Gonzalez, Carolina Maldonado iD, Nicholas Furtado, Ahmed Mohamed iD, Jenny Escalante, Marisel R Tuttobene iD, Araceli Quillen, Claudia Fontan und 6 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von German Matias Traglia und 17 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Salto 50000, Uruguay. Hauptthemen laut MEDLINE: Acinetobacter baumannii, beta-Lactamases, Acinetobacter Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of antibiotic-resistant bacteria in clinical settings has become a significant global concern. Among these bacteria, Acinetobacter baumannii stands out due to its remarkable ability to acquire resistance genes and persist in hospital environments, leading to some of the most challenging infections. Horizontal gene transfer (HGT) plays a crucial role in the evolution of this pathogen. The A. baumannii AMA205 strain, belonging to sequence type ST79, was isolated from a COVID-19 patient in Argentina in 2021. This strain’s antimicrobial resistance profile is notable as it harbors multiple resistance genes, some of which had not been previously described in this species. The AmpC family β-lactamase blaCMY-6, commonly found in Enterobacterales, had never been detected in A. baumannii before. Furthermore, this is the first ST79 strain known to carry the carbapenemase blaNDM-1 gene. Other acquired resistance genes include the carbapenemase blaOXA-23, further complicating treatment. Susceptibility testing revealed high resistance to most antibiotic families, including cefiderocol, with significant contributions from blaCMY-6 and blaNDM-1 genes to the cephalosporin and carbapenem resistance profiles. The A. baumannii AMA205 genome also contains genetic traits coding for 111 potential virulence factors, such as the iron-uptake system and biofilm-associated proteins. This study underscores A. baumannii’s ability to acquire multiple resistance genes and highlights the need for alternative therapies and effective antimicrobial stewardship to control the spread of these highly resistant strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniibeta-LactamasesAcinetobacter InfectionsAnti-Bacterial AgentsHumansCOVID-19Bacterial ProteinsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsGene Transfer, HorizontalSARS-CoV-2Genome, BacterialArgentinaVirulence Factors

Stichwörter der Autor:innen

AcinetobacterCMY-6DNA acquisitionantibiotic resistancecarbapenemases

Substanzen

beta-LactamasesAnti-Bacterial AgentsBacterial ProteinsVirulence Factors

Autor:innen und Institutionen

  • Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Salto 50000, Uruguay.
  • National Regional Reference Laboratory for Antimicrobial Resistance (NRL), Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos G. Malbrán, Buenos Aires C1282AFF, Argentina.
  • Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
  • Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario 2000, Argentina.
  • Hospital 4 de Junio, Dr. Ramon Carrillo, Roque Saenz Peña, Santiago del Estero H3700, Argentina.
  • Research Service and GRECC, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA.

ORCID-Profile: German Matias Traglia, Fernando Pasteran, Carolina Maldonado, Ahmed Mohamed, Marisel R Tuttobene, Marcelo E Tolmasky, Maria Soledad Ramirez

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • BLRD VA
  • NIH
  • Cleveland Department of Veterans Affairs
  • U-RISE

Zitieren

APA

Traglia, G. M., Pasteran, F., Moheb, S., Akhtar, U., Gonzalez, S., Maldonado, C., Furtado, N., Mohamed, A., Escalante, J., Tuttobene, M. R., Quillen, A., Fontan, C., Albornoz, E., Corso, A., Bonomo, R. A., Rao, G. G., Tolmasky, M. E., & Ramirez, M. S. (2024). Insights into Acinetobacter baumannii AMA205’s Unprecedented Antibiotic Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111424

Vancouver

Traglia GM, Pasteran F, Moheb S, Akhtar U, Gonzalez S, Maldonado C, et al. Insights into Acinetobacter baumannii AMA205’s Unprecedented Antibiotic Resistance. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111424

BibTeX
@article{Traglia2024,
  author = {Traglia, German Matias and Pasteran, Fernando and Moheb, Samyar and Akhtar, Usman and Gonzalez, Sebastian and Maldonado, Carolina and Furtado, Nicholas and Mohamed, Ahmed and Escalante, Jenny and Tuttobene, Marisel R and Quillen, Araceli and Fontan, Claudia and Albornoz, Ezequiel and Corso, Alejandra and Bonomo, Robert A and Rao, Gauri G and Tolmasky, Marcelo E and Ramirez, Maria Soledad},
  title = {Insights into Acinetobacter baumannii AMA205’s Unprecedented Antibiotic Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111424}
}
Kostenlos starten →